Establishing secure connection…Loading editor…Preparing document…

Vyvanse Prior Authorization Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Vyvanse Prior Authorization Form

Complete all sections. Incomplete or illegible forms will delay authorization. Attach relevant clinical records, recent progress notes, medication trials, and weight/vital signs where applicable. The undersigned authorizes release of medical information necessary to process this request.

Patient Information

Patient Name:

Date of Birth:   Gender: Male Female Other

Insurance and Billing

Member ID:   Group #:

Subscriber Relationship to Patient: Self Spouse Parent Other

Prescriber Information

Prescriber Name:

NPI #:   DEA #:

Office Phone:   Fax:

Medication Request

Medication Requested: Vyvanse (lisdexamfetamine) — Strength/Requested Dose:

Quantity per 30 days:   Refills:

Clinical/Medical Necessity

Has patient previously trialed amphetamine or methylphenidate therapies? Yes No

Patient Weight:   Height:

Safety / Contraindications

History of cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, or hypersensitivity to stimulants: Yes No

For females of reproductive potential: Has a pregnancy test been performed? Yes No   If yes, date of test:

Attachments and Documentation

Attach relevant documents: recent office notes, symptom rating scales, prior authorization denial letters, laboratory results (if applicable), and medication history.

Supporting Documentation Attached: Office Notes Medication History Other

Authorization and Release

By signing below, the patient or authorized representative authorizes release of medical records and information necessary to process this prior authorization request to the payer, pharmacy benefit manager, and dispensing pharmacy. This authorization includes mental health, substance use disorder, and medication treatment records where relevant.

I certify that the information provided is true and accurate to the best of my knowledge and that submission of false or misleading information may result in denial of coverage. I understand that approval of this request is a determination by the payer and not a guarantee of reimbursement.

Prescriber Attestation

The prescriber attests that the medication is medically necessary, that non-controlled and less-restrictive alternatives have been considered where clinically appropriate, and that risks, benefits, and monitoring requirements have been discussed with the patient.

Prescriber Printed Name:   Date:

Prescriber Contact for Appeal/Questions:

Patient Authorization / Acknowledgement

I authorize the prescriber to submit this prior authorization on my behalf and acknowledge that complete and accurate information has been provided. I understand that the insurer may contact my prescriber for clarification or additional records.

Patient acknowledges receipt of privacy information and consents to the release of protected health information for the purpose of prior authorization and payment.
I acknowledge and consent

Patient Printed Name:

Relationship to Patient (if signed by representative):

Signature:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Vyvanse Prior Authorization Form Is

The Vyvanse Prior Authorization Form is a payer-facing healthcare form used to request coverage approval for lisdexamfetamine (Vyvanse). It documents clinical justification, diagnosis codes, prior therapies, and prescriber details so a health plan can evaluate medical necessity before authorizing the prescription. The form helps standardize reviewer information, reduces back-and-forth between prescriber offices and payers, and is commonly required for managed care, Medicaid, and some commercial plans when prescribing controlled stimulants.

Why a Proper Prior Authorization Form Matters

A complete Vyvanse Prior Authorization Form speeds coverage decisions, reduces denials, and documents medical necessity for a controlled stimulant. Proper completion protects patient access to therapy while maintaining payer and regulatory requirements under healthcare privacy and prescribing rules.

Why a Proper Prior Authorization Form Matters

Who typically completes and reviews this form

Clinical staff, prescribers, pharmacists, and payer utilization reviewers interact with the Vyvanse Prior Authorization Form at different stages of the request and adjudication process.

  • Prescribers and office staff prepare clinical history and sign authorization information before submission.
  • Pharmacists may assemble prior authorization paperwork and submit via portal or fax when permitted.
  • Payer utilization reviewers assess clinical criteria, prior therapies, and diagnosis codes to approve or deny coverage.

Ensuring each role provides accurate, consistent details reduces delays and minimizes rework during peer-to-peer reviews or appeals.

Step-by-step: completing and submitting a prior authorization

Follow these core steps to assemble and submit a Vyvanse prior authorization efficiently.

  • 01
    Gather records: Collect clinical notes, prior meds, and lab results supporting treatment.
  • 02
    Complete form: Enter patient, prescriber, diagnosis, and prior therapy details accurately.
  • 03
    Attach documents: Add supporting evidence such as physician notes and medication history.
  • 04
    Submit: Send via payer portal, fax, or electronic submission per payer guidelines.

How to set up an electronic workflow for this form

Configure a repeatable digital workflow to capture required fields, attachments, and signer verification for payer submission.

Field Mapping Map form fields to EHR or practice management fields for auto-population.
Authentication Require authenticated prescriber sign-off using NPI-based verification or secure e-sign.
Attachments Enforce required attachments: office notes, med history, and relevant labs.
Routing Route to billing or prior auth team for final review before sending.
Submission Method Select payer-specific channel: portal upload, EDI, or fax fallback.

Digital signing and integration requirements

Use a compliant e-signature and document platform that supports secure attachments, audit trails, and integrations with clinical systems.

  • File formats: PDF, DOCX accepted
  • Integrations: EHR, Google Workspace, NetSuite
  • Security: TLS 1.2/1.3, AES-256

Ensure the platform supports HIPAA Business Associate Agreements, audit trails, and conditional fields to meet payer and regulatory expectations.

Where and how to send the completed form

Choose the payer's preferred submission path to avoid delays; common channels include payer portals, secure fax, and electronic data interchange (EDI).

  • Payer Portal: Upload completed form and attachments directly for fastest handling.
  • Secure Fax: Use cover sheet with HIPAA precautions when portals are unavailable.
  • EDI / HL7: Use EDI connections for batch submissions when supported.
  • Pharmacy Hub: Some manufacturers or hubs submit on behalf of prescribers.

Essential sections of a professional prior authorization form

A complete Vyvanse prior authorization form contains structured clinical and administrative sections. Each section is intended to supply the payer with a clear, auditable rationale for treatment approval.

Patient details

Full patient identifiers, insurance information, and demographic items required for accurate payer matching and claim routing.

Clinical history

Relevant psychiatric or ADHD history, symptom severity, functional impairment, and prior treatment responses to support medical necessity.

Prior medications

Detailed listing of prior stimulant and nonstimulant therapies, doses, durations, and documented reasons for discontinuation or lack of efficacy.

Diagnosis coding

Principal ICD-10 code with supporting secondary codes where applicable to align with payer coverage criteria.

Prescriber verification

Prescriber name, NPI, DEA when required, signature, and best contact for peer-to-peer review or clarifying questions.

Supporting attachments

Office notes, behavior rating scales, prior authorization letters, and objective testing that substantiate the clinical decision.

Common supporting documents to include

Attach concise, relevant evidence to accelerate review and reduce the likelihood of an information request or denial.

Office progress notes

Recent clinical notes documenting symptoms, functional impact, prior treatments, and rationale for Vyvanse rather than alternative therapies.

Medication history

Pharmacy fill history or e-prescribing log showing prior agents, dates, and documented failures or intolerances.

Assessment scales

If used, include standardized ADHD or relevant behavior rating scales that quantify severity and treatment need.

Peer documentation

Documentation of prior telephonic or written peer-to-peer discussions, if any, to show earlier clinical dialogue with the payer.

Practical tips to reduce processing time

Adopt these practical habits to minimize denials and accelerate payer response times.

Prepopulate recurring fields
Use templates or EHR field mapping to prefill patient and prescriber data, reducing typographical errors that cause manual rework and resubmission.
Attach concise evidence
Provide short, targeted clinical excerpts (one to two pages) that directly support the prior authorization criteria rather than broad chart dumps.
Verify payer rules
Confirm specific payer criteria for Vyvanse, including step therapy or required trials, before submission to avoid automatic denials.
Record peer contacts
Document peer-to-peer calls and include contact names and dates to speed appeals and elevate urgent cases.

Common mistakes that delay approval

  • Using inconsistent patient identifiers across attachments leading to payer mismatches and manual reassignments.
  • Failing to list prior therapies with exact dates and doses, which often triggers requests for additional clinical detail.
  • Submitting incomplete prescriber credentials or omitting required prescriber signatures that invalidate the request.
  • Including extraneous records without highlighting relevant excerpts, increasing reviewer effort and processing time.

Risks and consequences of incorrect submissions

Claim Denial: Coverage may be denied
Treatment Delay: Patient access delayed
HIPAA Risk: Privacy exposure possible
Regulatory Review: Prescribing practices examined
Rebilling: Administrative rework required
Appeals Burden: Time-consuming appeals

eSignature vendor comparison for healthcare prior authorization workflows

Comparison of basic vendor pricing and availability for HIPAA-capable eSignature plans. signNow is listed first in accordance with vendor ordering requirements.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Real-world examples of digital signing in healthcare workflows

These examples illustrate how organizations used digital signing and automated workflows to manage sensitive clinical forms and approvals.

Fertility Centers of Illinois

The clinic standardized online forms and eSign workflows to collect patient consents quickly

  • This reduced in-person processing time and document loss
  • John Butler, Founder, noted the API and responsiveness improved operational efficiency and compliance.

Xerox (NetSuite operations)

Xerox integrated eSignature into back-office workflows to ensure correct routing and tracking

  • Integration with ERP supported bulk processing
  • Kodi-Marie Evans, Director of NetSuite Operations, cited flexibility and format support as key benefits.

Key patient and prescriber data to protect

Patient Name: Full legal name
Date of Birth: MM/DD/YYYY
Medication: Lisdexamfetamine dosing
Diagnosis Code: ICD-10 code
Prescriber NPI: NPI and contact
Insurance ID: Subscriber ID and group

Frequently asked questions about Vyvanse prior authorization

Answers to common questions about form completion, e-signing, documentation, and what to expect during payer review.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.